BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 9600224)

  • 1. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein kinase II alteration precedes tau accumulation in tangle formation.
    Masliah E; Iimoto DS; Mallory M; Albright T; Hansen L; Saitoh T
    Am J Pathol; 1992 Feb; 140(2):263-8. PubMed ID: 1739121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1997 Mar; 56(3):285-90. PubMed ID: 9056542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional quantitative study of formation process of neurofibrillary tangles in the hippocampus of non-demented elderly brains: comparison with late-onset Alzheimer's disease brains.
    Takayama N; Iseki E; Yamamoto T; Kosaka K
    Neuropathology; 2002 Sep; 22(3):147-53. PubMed ID: 12416553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neurofibrillary tangles in Alzheimer disease.
    Brion JP
    Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear pore complex proteins in Alzheimer disease.
    Sheffield LG; Miskiewicz HB; Tannenbaum LB; Mirra SS
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):45-54. PubMed ID: 16410748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
    García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
    J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease.
    Kobayashi K; Nakano H; Hayashi M; Shimazaki M; Fukutani Y; Sasaki K; Sugimori K; Koshino Y
    J Neurol Sci; 2003 Apr; 208(1-2):17-24. PubMed ID: 12639720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles.
    Lauckner J; Frey P; Geula C
    Neurobiol Aging; 2003 Oct; 24(6):767-76. PubMed ID: 12927759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are tangles as toxic as they look?
    Spires-Jones TL; Kopeikina KJ; Koffie RM; de Calignon A; Hyman BT
    J Mol Neurosci; 2011 Nov; 45(3):438-44. PubMed ID: 21638071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer's disease.
    Hondius DC; Koopmans F; Leistner C; Pita-Illobre D; Peferoen-Baert RM; Marbus F; Paliukhovich I; Li KW; Rozemuller AJM; Hoozemans JJM; Smit AB
    Acta Neuropathol; 2021 Mar; 141(3):341-358. PubMed ID: 33492460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between amyloid and tau.
    Hardy J
    J Mol Neurosci; 2003 Apr; 20(2):203-6. PubMed ID: 12794314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
    Regalado-Reyes M; Furcila D; Hernández F; Ávila J; DeFelipe J; León-Espinosa G
    J Alzheimers Dis; 2019; 69(1):277-288. PubMed ID: 30958368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease.
    Pooler AM; Polydoro M; Maury EA; Nicholls SB; Reddy SM; Wegmann S; William C; Saqran L; Cagsal-Getkin O; Pitstick R; Beier DR; Carlson GA; Spires-Jones TL; Hyman BT
    Acta Neuropathol Commun; 2015 Mar; 3():14. PubMed ID: 25853174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain.
    Su JH; Deng G; Cotman CW
    Brain Res; 1997 Nov; 774(1-2):193-9. PubMed ID: 9452208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.
    Braak E; Braak H; Mandelkow EM
    Acta Neuropathol; 1994; 87(6):554-67. PubMed ID: 7522386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):158-67. PubMed ID: 17279001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.